Cointime

Agios Pharmaceuticals

company

About

Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.

  • 101 - 250

Highlights

Total Funding Amount
$111M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series C
Last Funding Money Raised
$78M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2008
Number Of Employee
101 - 250
Operating Status
Active

Agios Pharmaceuticals is a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism. It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases. Agios Pharmaceuticals was formerly known as CANCER METABOLISM THERAPEUTICS And changed its name to Agios Pharmaceuticals In April 2008. The company is based in Cambridge, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$111M
Agios Pharmaceuticals has raised a total of $111M in funding over 2 rounds. Their latest funding was raised on Nov 17, 2011 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 17, 2011 Series C $78M 1 — — Detail
Jul 7, 2008 Series A $33M 1 ARCH Venture Partners — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Agios Pharmaceuticals is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners — Series C
Cointime
Chủ Đề
Công Ty